Healthcare provider profile · identity verified

Robert Bruce Allison, D.O

Family Practice · MORGANTOWN, WV · NPI 1477849743

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	376	104
Amlodipine Besylate	Amlodipine Besylate	212	60
Levothyroxine Sodium	Levothyroxine Sodium	203	58
Lisinopril	Lisinopril	193	55
Omeprazole	Omeprazole	192	62
Losartan Potassium	Losartan Potassium	181	48
Gabapentin	Gabapentin	166	44
Metoprolol Succinate	Metoprolol Succinate	162	49
Rosuvastatin Calcium	Rosuvastatin Calcium	138	40
Eliquis	Apixaban	127	30
Fluticasone Propionate	Fluticasone Propionate	117	37
Hydrochlorothiazide	Hydrochlorothiazide	111	32
Metformin Hcl	Metformin Hcl	108	31
Tramadol Hcl	Tramadol Hcl	107	22
Metformin Hcl Er	Metformin Hcl	102	35
Tamsulosin Hcl	Tamsulosin Hcl	102	34
Pantoprazole Sodium	Pantoprazole Sodium	96	36
Montelukast Sodium	Montelukast Sodium	95	31
Ozempic	Semaglutide	87	15
Diclofenac Sodium	Diclofenac Sodium	82	22
Duloxetine Hcl	Duloxetine Hcl	81	21
Albuterol Sulfate Hfa	Albuterol Sulfate	76	23
Escitalopram Oxalate	Escitalopram Oxalate	69	23
Sertraline Hcl	Sertraline Hcl	67	23
Donepezil Hcl	Donepezil Hcl	63	12
Carvedilol	Carvedilol	62	18
Alendronate Sodium	Alendronate Sodium	61	20
Trazodone Hcl	Trazodone Hcl	61	20
Simvastatin	Simvastatin	60	19
Furosemide	Furosemide	59	16
Allopurinol	Allopurinol	53	16
Bupropion Xl	Bupropion Hcl	52	12
Famotidine	Famotidine	48	19
Metoprolol Tartrate	Metoprolol Tartrate	47	16
Mounjaro	Tirzepatide	46	suppressed
Prednisone	Prednisone	46	29
Enalapril Maleate	Enalapril Maleate	43	13
Esomeprazole Magnesium	Esomeprazole Magnesium	43	11
Mirtazapine	Mirtazapine	42	12
Pravastatin Sodium	Pravastatin Sodium	42	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	41	11
Ezetimibe	Ezetimibe	40	13
Meloxicam	Meloxicam	40	15
Spironolactone	Spironolactone	40	12
Potassium Chloride	Potassium Chloride	38	12
Acetaminophen-Codeine	Acetaminophen With Codeine	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	12
Finasteride	Finasteride	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Solifenacin Succinate	Solifenacin Succinate	35	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	24
Buspirone Hcl	Buspirone Hcl	31	11
Terazosin Hcl	Terazosin Hcl	31	suppressed
Celecoxib	Celecoxib	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	23
Lorazepam	Lorazepam	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Atenolol	Atenolol	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Nitroglycerin	Nitroglycerin	25	16
Trulicity	Dulaglutide	24	suppressed
Risperidone	Risperidone	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Glipizide	Glipizide	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Rivastigmine	Rivastigmine Tartrate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Ciclopirox	Ciclopirox	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Felodipine Er	Felodipine	14	suppressed
Hydroxyurea	Hydroxyurea	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Zolmitriptan	Zolmitriptan	14	suppressed
Glipizide Er	Glipizide	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Primidone	Primidone	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Theophylline Er	Theophylline Anhydrous	12	suppressed
Belsomra	Suvorexant	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error